Page last updated: 2024-10-30

ketotifen and Lichen Simplex Chronicus

ketotifen has been researched along with Lichen Simplex Chronicus in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Research Excerpts

ExcerptRelevanceReference
"17 children suffering from neurodermatitis, aged 2 to 14 years, were treated with ketotifen at a dosage of 1 mg twice daily."7.68Effectiveness of ketotifen in the treatment of neurodermatitis in childhood. ( Kikindjanin, V; Stevanocvić, V; Vukaviíc, T, 1990)
"17 children suffering from neurodermatitis, aged 2 to 14 years, were treated with ketotifen at a dosage of 1 mg twice daily."3.68Effectiveness of ketotifen in the treatment of neurodermatitis in childhood. ( Kikindjanin, V; Stevanocvić, V; Vukaviíc, T, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikindjanin, V1
Vukaviíc, T1
Stevanocvić, V1

Other Studies

1 other study available for ketotifen and Lichen Simplex Chronicus

ArticleYear
Effectiveness of ketotifen in the treatment of neurodermatitis in childhood.
    Dermatologische Monatschrift, 1990, Volume: 176, Issue:12

    Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Female; Humans; Ketotifen; Long-Term C

1990